Innovative Plant-based Vaccine Technologies: Spotlight on Medicago

In the current global crisis brought on by COVID-19, companies like Quebec City-based vaccine producer, Medicago, are critical to improving global health through innovative vaccine technologies. Medicago is part of Canada’s thriving the life sciences industry has been an important player in finding clinical solutions to immunize humans and help our health systems. In this episode of Invest in Canada’s collaboration with The Hill, we learn how Medicago, a biopharmaceutical company and pioneer in plant-based therapeutics technology, is producing vaccines at a faster rate than the traditional egg-based technology. Medicago has been able to produce vaccines within five to six weeks compared to egg-based vaccines which take approximately five to six months. Medicago’s journey began as a partnership with the University of Laval and the company has received support from federal programs available in the life sciences industry. In 2019, Medicago was awarded for the “best new vaccine technology/platform” at the world vaccine congress in Washington, DC. With more than 450 employees, Medicago holds offices both in Canada and North Carolina, United States. On October 23, 2020, it was announced that Medicago would supply the Canadian government with millions of doses of its vaccine against COVID-19, pending Health Canada approval. Medicago will also receive $173M in funding for vaccine research and development, and domestic manufacturing capacity. For more information, visit:   Medicago’s technologies are a testament to the innovation taking place within Canada’s life sciences industry. For more information on the industry and opportunities it presents for investment, visit: Subscribe to Invest in Canada for more information about our world-leading industries, diverse talent, low business costs, and more.   ***   To discover why Canada is the ideal investment destination, visit our website: ***   Follow us for updates from Invest in Canada:   Twitter:    LinkedIn:    Instagram: